These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


446 related items for PubMed ID: 21188648

  • 1. Genetics and immunopathogenesis of IgA nephropathy.
    Yu HH, Chu KH, Yang YH, Lee JH, Wang LC, Lin YT, Chiang BL.
    Clin Rev Allergy Immunol; 2011 Oct; 41(2):198-213. PubMed ID: 21188648
    [Abstract] [Full Text] [Related]

  • 2. Aberrant glycosylation of IgA1 and anti-glycan antibodies in IgA nephropathy: role of mucosal immune system.
    Novak J, Moldoveanu Z, Julian BA, Raska M, Wyatt RJ, Suzuki Y, Tomino Y, Gharavi AG, Mestecky J, Suzuki H.
    Adv Otorhinolaryngol; 2011 Oct; 72():60-3. PubMed ID: 21865691
    [Abstract] [Full Text] [Related]

  • 3. Immunopathogenesis of IgAN.
    Barratt J, Smith AC, Molyneux K, Feehally J.
    Semin Immunopathol; 2007 Nov; 29(4):427-43. PubMed ID: 17851660
    [Abstract] [Full Text] [Related]

  • 4. The pathogenic role of IgA1 O-linked glycosylation in the pathogenesis of IgA nephropathy.
    Barratt J, Smith AC, Feehally J.
    Nephrology (Carlton); 2007 Jun; 12(3):275-84. PubMed ID: 17498123
    [Abstract] [Full Text] [Related]

  • 5. Pathogenesis of IgA nephropathy.
    Lai KN.
    Nat Rev Nephrol; 2012 Mar 20; 8(5):275-83. PubMed ID: 22430056
    [Abstract] [Full Text] [Related]

  • 6. Pathogenesis of IgA nephropathy.
    Feehally J, Allen AC.
    Ann Med Interne (Paris); 1999 Feb 20; 150(2):91-8. PubMed ID: 10392257
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. IgA nephropathy and Henoch-Schoenlein purpura nephritis: aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cells.
    Novak J, Moldoveanu Z, Renfrow MB, Yanagihara T, Suzuki H, Raska M, Hall S, Brown R, Huang WQ, Goepfert A, Kilian M, Poulsen K, Tomana M, Wyatt RJ, Julian BA, Mestecky J.
    Contrib Nephrol; 2007 Feb 20; 157():134-8. PubMed ID: 17495451
    [Abstract] [Full Text] [Related]

  • 9. Aberrant Glycosylation of the IgA1 Molecule in IgA Nephropathy.
    Novak J, Barratt J, Julian BA, Renfrow MB.
    Semin Nephrol; 2018 Sep 20; 38(5):461-476. PubMed ID: 30177018
    [Abstract] [Full Text] [Related]

  • 10. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases.
    Tissandié E, Morelle W, Berthelot L, Vrtovsnik F, Daugas E, Walker F, Lebrec D, Trawalé JM, Francoz C, Durand F, Moura IC, Paradis V, Moreau R, Monteiro RC.
    Kidney Int; 2011 Dec 20; 80(12):1352-63. PubMed ID: 21866091
    [Abstract] [Full Text] [Related]

  • 11. IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy.
    Novak J, Julian BA, Tomana M, Mestecky J.
    Semin Nephrol; 2008 Jan 20; 28(1):78-87. PubMed ID: 18222349
    [Abstract] [Full Text] [Related]

  • 12. Pathogenic role of glycan-specific IgG antibodies in IgA nephropathy.
    Zhao YF, Zhu L, Liu LJ, Shi SF, Lv JC, Zhang H.
    BMC Nephrol; 2017 Sep 29; 18(1):301. PubMed ID: 28969604
    [Abstract] [Full Text] [Related]

  • 13. Humoral immunity against the proline-rich peptide epitope of the IgA1 hinge region in IgA nephropathy.
    Kokubo T, Hashizume K, Iwase H, Arai K, Tanaka A, Toma K, Hotta K, Kobayashi Y.
    Nephrol Dial Transplant; 2000 Jan 29; 15(1):28-33. PubMed ID: 10607764
    [Abstract] [Full Text] [Related]

  • 14. Sialylation of IgG inhibits the formation of galactose-deficient IgA1-containing immune complexes and protects mesangial cells from injury in IgA nephropathy.
    Liu Y, Li H, Yu H, Wang F, Jia J, Yan T.
    BMC Nephrol; 2022 Jan 11; 23(1):25. PubMed ID: 35016642
    [Abstract] [Full Text] [Related]

  • 15. Mesangial cells from patients with IgA nephropathy have increased susceptibility to galactose-deficient IgA1.
    Ebefors K, Liu P, Lassén E, Elvin J, Candemark E, Levan K, Haraldsson B, Nyström J.
    BMC Nephrol; 2016 Apr 05; 17():40. PubMed ID: 27044423
    [Abstract] [Full Text] [Related]

  • 16. Transferrin receptor engagement by polymeric IgA1 induces receptor expression and mesangial cell proliferation: role in IgA nephropathy.
    Tamouza H, Vende F, Tiwari M, Arcos-Fajardo M, Vrtovsnik F, Benhamou M, Monteiro RC, Moura IC.
    Contrib Nephrol; 2007 Apr 05; 157():144-7. PubMed ID: 17495453
    [Abstract] [Full Text] [Related]

  • 17. The genetic susceptibility to IgA nephropathy: a novel functional candidate gene for incomplete O-glycosylation of IgA1.
    Narita I, Kaneko Y, Kondo D, Goto S, Sakatsume M, Gejyo F.
    Kidney Int; 2007 Mar 05; 71(5):379-81. PubMed ID: 17315006
    [Abstract] [Full Text] [Related]

  • 18. IgA nephropathy enigma.
    Mestecky J, Novak J, Moldoveanu Z, Raska M.
    Clin Immunol; 2016 Nov 05; 172():72-77. PubMed ID: 27444044
    [Abstract] [Full Text] [Related]

  • 19. The IgA1 immune complex-mediated activation of the MAPK/ERK kinase pathway in mesangial cells is associated with glomerular damage in IgA nephropathy.
    Tamouza H, Chemouny JM, Raskova Kafkova L, Berthelot L, Flamant M, Demion M, Mesnard L, Paubelle E, Walker F, Julian BA, Tissandié E, Tiwari MK, Camara NO, Vrtovsnik F, Benhamou M, Novak J, Monteiro RC, Moura IC.
    Kidney Int; 2012 Dec 05; 82(12):1284-96. PubMed ID: 22951891
    [Abstract] [Full Text] [Related]

  • 20. Murine Models of Human IgA Nephropathy.
    Suzuki H, Suzuki Y.
    Semin Nephrol; 2018 Sep 05; 38(5):513-520. PubMed ID: 30177023
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.